Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Russian nursing students' knowledge level and attitudes in the context of human immunodeficiency virus (HIV) - a descriptive study.

Suominen T, Laakkonen L, Lioznov D, Polukova M, Nikolaenko S, Lipiäinen L, Välimäki M, Kylmä J.

BMC Nurs. 2015 Jan 8;14(1):1. doi: 10.1186/s12912-014-0053-7. eCollection 2015.

2.

Fibrinolytic and coagulative activities of Yersinia pestis.

Korhonen TK, Haiko J, Laakkonen L, Järvinen HM, Westerlund-Wikström B.

Front Cell Infect Microbiol. 2013 Jul 26;3:35. doi: 10.3389/fcimb.2013.00035. eCollection 2013. Review.

3.

Human single-chain urokinase is activated by the omptins PgtE of Salmonella enterica and Pla of Yersinia pestis despite mutations of active site residues.

Järvinen HM, Laakkonen L, Haiko J, Johansson T, Juuti K, Suomalainen M, Buchrieser C, Kalkkinen N, Korhonen TK.

Mol Microbiol. 2013 Aug;89(3):507-17. doi: 10.1111/mmi.12293. Epub 2013 Jul 11.

4.

Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiol.

Sneitz N, Vahermo M, Mosorin J, Laakkonen L, Poirier D, Finel M.

Drug Metab Dispos. 2013 Mar;41(3):582-91. doi: 10.1124/dmd.112.049072. Epub 2013 Jan 3.

PMID:
23288867
5.

Glutamine synthetase and glucose-6-phosphate isomerase are adhesive moonlighting proteins of Lactobacillus crispatus released by epithelial cathelicidin LL-37.

Kainulainen V, Loimaranta V, Pekkala A, Edelman S, Antikainen J, Kylväjä R, Laaksonen M, Laakkonen L, Finne J, Korhonen TK.

J Bacteriol. 2012 May;194(10):2509-19. doi: 10.1128/JB.06704-11. Epub 2012 Mar 2.

6.

Molecular adaptation of a plant-bacterium outer membrane protease towards plague virulence factor Pla.

Haiko J, Laakkonen L, Westerlund-Wikström B, Korhonen TK.

BMC Evol Biol. 2011 Feb 11;11:43. doi: 10.1186/1471-2148-11-43.

7.

Two distinct regions in the model protein Peb1 are critical for its heterologous transport out of Escherichia coli.

Anton L, Majander K, Savilahti H, Laakkonen L, Westerlund-Wikström B.

Microb Cell Fact. 2010 Dec 2;9:97. doi: 10.1186/1475-2859-9-97.

8.

The omptins of Yersinia pestis and Salmonella enterica cleave the reactive center loop of plasminogen activator inhibitor 1.

Haiko J, Laakkonen L, Juuti K, Kalkkinen N, Korhonen TK.

J Bacteriol. 2010 Sep;192(18):4553-61. doi: 10.1128/JB.00458-10. Epub 2010 Jul 16.

9.

A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme.

Laakkonen L, Finel M.

Mol Pharmacol. 2010 Jun;77(6):931-9. doi: 10.1124/mol.109.063289. Epub 2010 Mar 9.

PMID:
20215562
10.

How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?

Itäaho K, Laakkonen L, Finel M.

Drug Metab Dispos. 2010 Apr;38(4):687-96. doi: 10.1124/dmd.109.031229. Epub 2010 Jan 20.

PMID:
20089735
11.

The chemistry of the CuB site in cytochrome c oxidase and the importance of its unique His-Tyr bond.

Kaila VR, Johansson MP, Sundholm D, Laakkonen L, Wiström M.

Biochim Biophys Acta. 2009 Apr;1787(4):221-33.

12.

A complete Neandertal mitochondrial genome sequence determined by high-throughput sequencing.

Green RE, Malaspinas AS, Krause J, Briggs AW, Johnson PL, Uhler C, Meyer M, Good JM, Maricic T, Stenzel U, Prüfer K, Siebauer M, Burbano HA, Ronan M, Rothberg JM, Egholm M, Rudan P, Brajković D, Kućan Z, Gusić I, Wikström M, Laakkonen L, Kelso J, Slatkin M, Pääbo S.

Cell. 2008 Aug 8;134(3):416-26. doi: 10.1016/j.cell.2008.06.021.

13.

Modeling the active-site structure of the cbb3-type oxidase from Rhodobacter sphaeroides.

Sharma V, Wikström M, Laakkonen L.

Biochemistry. 2008 Apr 8;47(14):4221-7. doi: 10.1021/bi702088r. Epub 2008 Mar 14.

PMID:
18338855
14.

Charge parameterization of the metal centers in cytochrome c oxidase.

Johansson MP, Kaila VR, Laakkonen L.

J Comput Chem. 2008 Apr 15;29(5):753-67.

PMID:
17876762
15.

Dynamics of the glutamic acid 242 side chain in cytochrome c oxidase.

Tuukkanen A, Kaila VR, Laakkonen L, Hummer G, Wikström M.

Biochim Biophys Acta. 2007 Sep;1767(9):1102-6. Epub 2007 Jul 17.

16.
18.

The K-pathway revisited: a computational study on cytochrome c oxidase.

Tuukkanen A, Verkhovsky MI, Laakkonen L, Wikström M.

Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1117-21. Epub 2006 Jun 7.

19.

Sequence analysis of the cbb3 oxidases and an atomic model for the Rhodobacter sphaeroides enzyme.

Sharma V, Puustinen A, Wikström M, Laakkonen L.

Biochemistry. 2006 May 9;45(18):5754-65.

PMID:
16669619
20.

Gating of proton and water transfer in the respiratory enzyme cytochrome c oxidase.

Wikström M, Ribacka C, Molin M, Laakkonen L, Verkhovsky M, Puustinen A.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10478-81. Epub 2005 Jul 13.

21.

Adaptive evolution of cytochrome c oxidase: Infrastructure for a carnivorous plant radiation.

Jobson RW, Nielsen R, Laakkonen L, Wikström M, Albert VA.

Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18064-8. Epub 2004 Dec 13.

23.

Probing the ability of the coat and vertex protein of the membrane-containing bacteriophage PRD1 to display a meningococcal epitope.

Huiskonen JT, Laakkonen L, Toropainen M, Sarvas M, Bamford DH, Bamford JK.

Virology. 2003 Jun 5;310(2):267-79.

24.

Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.

Medina OP, Söderlund T, Laakkonen LJ, Tuominen EK, Koivunen E, Kinnunen PK.

Cancer Res. 2001 May 15;61(10):3978-85.

25.

The structure of the ubiquinol oxidase from Escherichia coli and its ubiquinone binding site.

Abramson J, Riistama S, Larsson G, Jasaitis A, Svensson-Ek M, Laakkonen L, Puustinen A, Iwata S, Wikström M.

Nat Struct Biol. 2000 Oct;7(10):910-7.

PMID:
11017202
26.

Interaction between the formyl group of heme a and arginine 54 in cytochrome aa(3) from Paracoccus denitrificans.

Riistama S, Verkhovsky MI, Laakkonen L, Wikström M, Puustinen A.

Biochim Biophys Acta. 2000 Jan 3;1456(1):1-4.

27.

3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.

Filizola M, Laakkonen L, Loew GH.

Protein Eng. 1999 Nov;12(11):927-42.

PMID:
10585498
28.

The calcium binding site in cytochrome aa3 from Paracoccus denitrificans.

Riistama S, Laakkonen L, Wikström M, Verkhovsky MI, Puustinen A.

Biochemistry. 1999 Aug 17;38(33):10670-7.

PMID:
10451361
29.
30.
31.

Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.

Laakkonen L, Li W, Perlman JH, Guarnieri F, Osman R, Moeller KD, Gershengorn MC.

Mol Pharmacol. 1996 Jun;49(6):1092-6.

PMID:
8649348
32.

Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.

Perlman JH, Laakkonen L, Osman R, Gershengorn MC.

Mol Pharmacol. 1995 Mar;47(3):480-4.

PMID:
7700246
33.
34.

Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor.

Perlman JH, Thaw CN, Laakkonen L, Bowers CY, Osman R, Gershengorn MC.

J Biol Chem. 1994 Jan 21;269(3):1610-3.

35.

Analysis of the role of transmembrane helix three of the thyrotropin-releasing hormone (TRH) receptor in directly binding TRH.

Perlman JH, Laakkonen L, Thaw CN, Osman R, Gershengorn MC.

Trans Assoc Am Physicians. 1993;106:162-7. No abstract available.

PMID:
8036739

Supplemental Content

Loading ...
Support Center